Table 2 Different levels of prognostic factors.
Patient and Tumor | |||
|---|---|---|---|
Factor | No. | (%) | Levels |
Duration of adjuvant imatinib (m) | |||
0–11 | 90 | 48 | 0 |
12–24 | 40 | 22 | 1 |
25–36 | 30 | 16 | 2 |
37–48 | 3 | 2 | 3 |
49–60 | 15 | 8 | 4 |
>60 | 7 | 4 | 5 |
Tumor size (cm) | |||
≤5.0 | 56 | 30 | 1 |
5.1–10.0 | 78 | 42 | 2 |
10.1–15.0 | 37 | 20 | 3 |
15.0–20.0 | 10 | 7 | 4 |
>20 | 4 | 2 | 5 |
Tumor mitotic rate (count per 50 HPFs) | |||
≤5 | 32 | 17 | 1 |
6–10 | 53 | 28 | 2 |
11–15 | 36 | 20 | 3 |
16–20 | 27 | 15 | 4 |
>20 | 37 | 20 | 5 |
Tumor site | |||
Stomach | 124 | 67 | 0 |
Small intestine | 49 | 27 | 1 |
Colon or rectum | 12 | 6 | 1 |
GI bleeding | |||
Yes | 116 | 63 | 1 |
No | 69 | 37 | 0 |
